Vera Therapeutics, Inc. (NASDAQ:VERA) is one of the best small cap stocks with the highest upside. BofA initiated coverage of Vera Therapeutics, Inc. (NASDAQ:VERA) with a Buy rating and a $48 price target on October 16.
The firm told investors that it sees potential upside in the company’s shares because of its lead drug, atacicept, a novel biologic investigational therapeutic launching into a multibillion-dollar market.
The firm also stated that its $3 billion nominal peak sales estimation for 2037 shows atacicept’s potential as a favorable treatment option in several autoimmune disorders, pending future clinical data validation.
Vera Therapeutics, Inc. is a clinical-stage biotechnical company that develops and commercializes transformative treatments for immunological diseases.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.
This article is originally published at Insider Monkey.
